Soltis Investment Advisors »

Regeneron Pharmaceuticals shares owned by Soltis Investment Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Soltis Investment Advisors from 13F filings

Historical chart of Soltis Investment Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Soltis Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Soltis Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $649k 674 962.92
2023-12-31 $600k 683 878.59
2023-09-30 $597k 725 823.33
2023-06-30 $528k 734 718.86
2023-03-31 $610k 742 821.44
2022-12-31 $502k 695 721.67
2022-09-30 $486k 705 689.36
2022-06-30 $380k 642 591.90
2022-03-31 $441k 631 698.89
2021-12-31 $370k 586 631.40
2021-09-30 $356k 588 605.44
2021-06-30 $326k 584 558.22
2021-03-31 $263k 555 473.87
2020-12-31 $263k 544 483.46
2020-09-30 $297k 531 559.32
2020-06-30 $312k 500 624.00
2020-03-31 $244k 500 488.00